Inside these posts: Bladder cancer

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


FDA looks into diabetes drug, bladder cancer

The Food and Drug Administration said Friday that it has started a safety review of Takeda Pharmaceutical Co.’s  diabetes drug Actos looking at links to bladder cancer.

The FDA said the review was prompted from preliminary, five-year data from an ongoing study involving the drug. The study, designed to follow patients for 10-years, is being funded by Takeda. Get the full story »